Dnae / pathogen identification from specimen, via capture, extraction and sequencing (PISCES)

Active Definitive Contract Awarded Last action

Contract number
HHSO100201600017C
Awardee
Awarding agency
Obligated
$43,409,723

Award facts

Contract value 70% obligated
  • $43,409,723.20 Current, with exercised options
  • $61,911,404.20 Potential, with all options
Completion date 99% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Sharing
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Supplemental Agreement for work within scope P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $10,100,000
Other Administrative Action P00009 · No cost extension to option 4 $0
Other Administrative Action P00008 · Incorporate far deviation clause 52.223-99, ensuring adequate covid safety protocols for federal contractors $0
Change Order P00007 · DE-obligate remaining FY2016 expiring funds from CLIN0001 -$49,053
Other Administrative Action P00006 · Change CO, CS, and COR $0
Exercise an Option P00005 · Exercise of clin 0006 (option 4) beta platform for pathogen identification from specimen, via capture, extraction and sequencing (PISCES) $13,882,917
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Exercise an Option 1 $10,982,121
Original award $8,493,738
Show all 15

About this award

The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a definitive contract to DNAE Group Holdings LIMITED (doing business as DNAE) on September 28, 2016, for the Pathogen Identification from Specimen, via Capture, Extraction and Sequencing (PISCES) program. The contract, valued at approximately $61.9 million, utilizes a cost-sharing pricing structure and is scheduled for completion by December 31, 2026. DNAE, a United Kingdom-based firm, will perform work in Great Britain under this civilian contract, which was awarded without a set-aside designation.

The PISCES program represents ASPR's investment in advanced diagnostic capabilities for rapid pathogen identification, a critical component of the nation's preparedness and response infrastructure for infectious disease threats. This contract supports the development and delivery of diagnostic technologies that can efficiently identify pathogens from clinical specimens through capture, extraction, and sequencing methodologies. The multi-year engagement and significant financial commitment reflect the strategic importance of enhanced diagnostic capabilities in supporting public health emergency preparedness and response operations.

Quick answers

Who was awarded contract HHSO100201600017C?

HHSO100201600017C was awarded to Dnae Group Holdings LIMITED by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2016.

How much is contract HHSO100201600017C worth?

The government has obligated $43,409,723 on HHSO100201600017C. Its potential value, with all options, is $61,911,404.

Was contract HHSO100201600017C competed?

The extent of competition for HHSO100201600017C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award